<img src="https://ml.globenewswire.com/Resource/Download/52324ae5-4190-4acb-93b4-aa6f1c996843?size=2" nborder="0" align="left" hspace="5" vspace="5" title="mobia-medical-logo-color-rgb_400x400.png" alt="Mobia Medical, Inc."/>AUSTIN, Texas, July 21, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Company will report second quarter 2026 financial results on Tuesday, August 11, 2026. Mobia Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details Those interested in listening to the conference call should register online using <a href="https://www.globenewswire.com/Tracker?data=mdrG5GL6w9xS2e670aqnwZufh3I-F6T4307Z6nHmO6o59p1rIYWnginwk5OuxHjBKI853GQFlyuDqwoXlxKYNVO8gN4sAmUrRHyv6WyZTkHZj8k59adqoEol2npgJYkJQ55r5vnjjtrAiATTwkfClBPlCEmaRPbSsw9FNIZJSIg=" rel="nofollow" target="_blank" title="this link">this link</a>. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A live and archived webcast can also be accessed via the <a href="https://www.globenewswire.com/Tracker?data=Kp7n_s_10Eh9LelCR6ue_STgZzfgPbVM3Vzwtr2u1zCkc_Jyo0JnitEGl7TohIp2e68rN2abCmou8hCLqo57vglxGrUnNMu7ukkX-JByGAO827bWTBPBAKxrYZ1K0w3x" rel="nofollow" target="_blank" title="News &amp; Events">News &amp; Events</a> page of the investor section of Mobia Medical’s website. About Mobia Medical, Inc. Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care. Investor Relations Contact Louisa Smith Gilmartin Group, LLC investors@mobia.com <img alt="" src='https://ml.globenewswire.com/media/ZTY1OTRkNDEtM2U5Yi00ODEzLWEwNGUtMDQxYjQxMWJkNzcwLTEzMTk0NjAtMjAyNi0wNy0yMS1lbg==/tiny/Mobia-Medical-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn